"It has been a pleasure working closely with RoukenBio to evaluate the functional activity of our IgM antibodies in ex vivo primary cell assays. The scientific team at RoukenBio feels like an extension of our internal Preclinical Sciences team since they readily provide trouble-shooting input. Through multiple successful collaborations, RoukenBio has consistently delivered high quality, robust data. I highly recommend working with them!"

Maya Kotturi, Ph.D

Executive Director - Translational Research

"We initially reached out to RoukenBio 3 years ago to run intricate cell-based assays using primary immune cells; the company had come highly recommended by former colleagues. We were impressed right away by the depth of knowledge of the RoukenBio team and appreciated their input on our proposed experimental plans; the RoukenBio team excelled both at communicating and executing the work. I would highly recommend working with RoukenBio."

Bijan Etemad-Gilbertson, Ph.D

Vice President - Antibody Technology - NextPoint Therapeutics

"Collaborating with RoukenBio is like a natural extension of our internal team. The level at which RoukenBio inputs and buys into the project, along with their attention to close communication and detail, is not something we experience with other CROs and are key factors that drive project success."

Emily Corse, Ph.D.

Executive Vice President, Biology & Translation

"We have worked with RoukenBio for approximately 3 years to run various immune cell based functional assays that our teams did not have the capabilities or capacity to run. We have been delighted with the quality of data, the clear collaborative communication and troubleshooting that RoukenBio has provided over the years and we look forward to continuing to work with them in our drug development processes."

Dr Angus Sinclair

Executive Vice President Research

"I am extremely pleased with the service provided by RoukenBio. Their team is incredibly knowledgeable, ensuring that all my questions are answered thoroughly. They are also highly efficient with their time, making the entire process smooth and hassle-free. Most importantly, their customer-oriented approach makes me feel valued and well taken care of. Highly recommended!"

Arnab Bera

Director, Head of Potency and Binding Assays

"We approach RoukenBio for high complexity and high priority work, leveraging the extensive domain knowledge the team has accumulated to execute a broad variety of immunology assays. Having seen the organization expand over the past 8 years, I really appreciate that the thoughtful bespoke approach and the desire to get every project right have remained the essence of every interaction."

Dr. Johanna Kaufman

Chief Scientific Officer at Deck Bio

“When we expanded from ex-vivo into in-vivo cell therapy approaches for solid tumours, external specialists such as RoukenBio allowed us to test new ideas rapidly and generated early feasibility data before making larger internal investments. In that sense, they are not just extra capacity; they are a true extension of our R&D capabilities.”

Marleen von Loenen

Head of Discovery at T-Knife Therapeutics